Literature DB >> 23914212

Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial.

Zabiolah Shahmoradi1, Farib Iraji, Amir Hossein Siadat, Azamosadat Ghorbaini.   

Abstract

BACKGROUND: Acne vulgaris is considered one of the most common disorders for which patients seek dermatologic care. In the current study, we evaluated efficacy of the 5% nicotinamide gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris.
MATERIALS AND METHODS: This was a randomized, controlled clinical trial that was performed in 2009-2010. Sixty female patients with mild or moderate acne vulgaris were recurited to be treated either with 5% nicotinamide or 2% clindamycin gel for 8 weeks. Acne severity index (ASI) was used to evaluate response to treatment and SPSS software was used to analyze the data.
RESULTS: The mean of ASI at the baseline was 16.85 ± 8.5 and 18.2 ± 12.27 in nicotinamide gel and clindamycin gel, respectively (P > 0.05). The mean of ASI was significantly decreased compared with baseline ASI during the time in both groups (P < 0.0001). However, there was not a significant difference regarding reduction of ASI between the nicotinamide and clindamycin gel (P = 0.583).
CONCLUSION: Five percent nicotinamide gel is as effective as 2% clindamycin gel for treatment of mild to moderate acne vulgaris. No side effect was observed during the treatment.

Entities:  

Keywords:  Acne; clindamycin; nicotinamide; treatment

Year:  2013        PMID: 23914212      PMCID: PMC3724370     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


  15 in total

1.  The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study.

Authors:  Fariba Iraji; Ali Momeni; Seyed Morteza Naji; Amir Hossein Siadat
Journal:  Dermatol Online J       Date:  2006-03-30

2.  Nicotinic acid as an agent for counteracting iodide aggravation in acne vulgaris.

Authors:  S W BAREFOOT
Journal:  AMA Arch Derm       Date:  1955-04

3.  The treatment of acne vulgaris with nicotinic acid induced vasodilatation.

Authors:  W E MARCHAND
Journal:  Mil Med       Date:  1955-07       Impact factor: 1.437

4.  The effect of 2% niacinamide on facial sebum production.

Authors:  Zoe Diana Draelos; Akira Matsubara; Kenneth Smiles
Journal:  J Cosmet Laser Ther       Date:  2006-06       Impact factor: 2.247

5.  Nicotinic acid/niacinamide and the skin.

Authors:  W Gehring
Journal:  J Cosmet Dermatol       Date:  2004-04       Impact factor: 2.696

6.  The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.

Authors:  Shahla Enshaieh; Abolfazl Jooya; Amir Hossein Siadat; Fariba Iraji
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Jan-Feb       Impact factor: 2.545

Review 7.  Diagnosis and treatment of acne.

Authors:  Stephen Titus; Joshua Hodge
Journal:  Am Fam Physician       Date:  2012-10-15       Impact factor: 3.292

8.  Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris.

Authors:  Fariba Iraji; Ali Sadeghinia; Zabiholahi Shahmoradi; Amir Hossein Siadat; Abolfazl Jooya
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Mar-Apr       Impact factor: 2.545

9.  Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne.

Authors:  S Veraldi; G L Giovene; C Guerriero; V Bettoli
Journal:  G Ital Dermatol Venereol       Date:  2012-10       Impact factor: 2.011

10.  Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.

Authors:  A R Shalita; J G Smith; L C Parish; M S Sofman; D K Chalker
Journal:  Int J Dermatol       Date:  1995-06       Impact factor: 2.736

View more
  6 in total

1.  Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.

Authors:  Tarnyamas Kaewsanit; Panlop Chakkavittumrong; Neti Waranuch
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

2.  Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.

Authors:  Haibo Liu; Haiyan Yu; Jun Xia; Ling Liu; Guan J Liu; Hong Sang; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

Review 3.  Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy.

Authors:  Chee Leok Goh; Nopadon Noppakun; Giuseppe Micali; Noor Zalmy Azizan; Waranya Boonchai; Yung Chan; Wai Kwong Cheong; Pin Chi Chiu; Kristiana Etnawati; Zharlah Gulmatico-Flores; Henry Foong; Raj Kubba; Purita Paz-Lao; Yin Yin Lee; Steven Loo; Farida Modi; Trong Hao Nguyen; Thi Lan Pham; Yi Hsien Shih; Irma Bernadette Sitohang; Su Ni Wong
Journal:  J Cutan Aesthet Surg       Date:  2016 Apr-Jun

4.  Combined Cutaneous Therapy Using Biocompatible Metal-Organic Frameworks.

Authors:  Seyed Dariush Taherzade; Sara Rojas; Janet Soleimannejad; Patricia Horcajada
Journal:  Nanomaterials (Basel)       Date:  2020-11-25       Impact factor: 5.076

Review 5.  The Synergy between Pharmacological Regimens and Dermocosmetics and Its Impact on Adherence in Acne Treatment.

Authors:  Elena Araviiskaia; Alison Margaret Layton; Jose Luis López Estebaranz; Falk Ochsendorf; Giuseppe Micali
Journal:  Dermatol Res Pract       Date:  2022-08-09

Review 6.  Menopausal Acne - Challenges And Solutions.

Authors:  Niti Khunger; Krati Mehrotra
Journal:  Int J Womens Health       Date:  2019-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.